R&D Pipeline

Pipeline (2021-2030)

Respiratory - rProtein (1)

Modality Indication Targets Stage Company Project No. Detail
1 Derivation of lead candidates for idiopathic 
pulmonary fibrosis treatment through inhalant 
optimization of integrin selective binding peptide
rProtein IPF Integrin αVβ-3,5,6 Lead NEXEL HN22C0012